TCR2 Therapeutic (TCRR) a Potential Game-Changer in Solid Tumors Jan 10, 2021 TCR2 Therapeutic (TCRR) was a successful small cap Biotech in 2020 with shares gaining around 100% and will be presenting at the JP Morgan Healthcare... read more